当前位置: 首页 > 期刊 > 《新医学》 > 2022年第1期
编号:649982
肿瘤血管新生及中医药抗肿瘤血管新生的研究进展
http://www.100md.com 2022年2月16日 新医学 2022年第1期
血管内皮生长因子
     张金华 田园 杨晓萍

    【摘要】 肿瘤血管新生是肿瘤细胞、内皮细胞等相互作用的复杂过程,其受到多种促血管生长因子、抑制因子、信号通路等的调控,肿瘤血管新生促进肿瘤的发生发展、转移。近年来,不少研究证实一些具有扶正、化淤、解毒等功效的单味中药及活性成分、中药复方或中成药可通过促进肿瘤血管内皮细胞凋亡及抑制其增殖迁移,抑制血管生成因子等的表达,抑制基质金属蛋白酶的表达,多途径、多靶点抑制肿瘤血管新生。该文就肿瘤血管新生及中医药抗肿瘤血管新生研究进展作一综述。

    【关键词】 肿瘤;血管新生;血管内皮生长因子;中医药;机制

    Research progress on tumor angiogenesis and anti-tumor angiogenesis of traditional Chinese medicine Zhang Jinhua△, Tian Yuan,Yang Xiaoping. △Department of Oncology, Jingmen First People’s Hospital, Jingmen 448000,China

    Corresponding author,Zhang Jinhua, E-mail: okfrom@126.com

    【Abstract】 Tumor angiogenesis is a complex process of interaction between tumor cells and endothelial cells, which is regulated by a variety of angiogenic factors, inhibitors and signaling pathways, etc. Tumor angiogenesis promotes the incidence, development and metastasis of tumors. Recent studies have validated that some single traditional Chinese medicines and active ingredients, traditional Chinese medicine compounds or Chinese patent medicines with the functions of strengthening, removing blood stasis and detoxifying can promote the apoptosis of tumor vascular endothelial cells ......

您现在查看是摘要页,全文长 13180 字符